Medication: The smart-pill oversell

Sharpe, Katherine

doi:10.1038/506146a

Cited by 26 publications

(18 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition two articles gave voice to experts defending conflicting opinions about this protective effect (Table V). In agreement with the scientific consensus (Sharpe, 2014), only four articles stated that medication does not protect from the long-term risk of academic underachievement. All four articles cited US scientific studies that supported this negative conclusion.…”

Section: Resultsmentioning

confidence: 57%

“…However, this review also showed that the number of patients included in individual studies was multiplied 10-fold from the early 1990s to the late 2000s (Li et al, 2014). Epidemiological studies have shown that ADHD children are at an elevated risk of academic underachievement and that psychostimulant medication does not decrease this long-term risk (Sharpe, 2014). Despite premature claims (Dougherty et al, 1999), brain-imaging techniques cannot be used to diagnose ADHD.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

How French media have portrayed ADHD to the lay public and to social workers

Ponnou

Gonon

2017

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

Two models of attention deficit hyperactivity disorder (ADHD) coexist: the biomedical and the psychosocial. We identified in nine French newspapers 159 articles giving facts and opinions about ADHD from 1995 to 2015. We classified them according to the model they mainly supported and on the basis of what argument. Two thirds (104/159) mainly supported the biomedical model. The others either defended the psychodynamic understanding of ADHD or voiced both models. Neurological dysfunctions and genetic risk factors were mentioned in support of the biomedical model in only 26 and eight articles, respectively. These biological arguments were less frequent in the most recent years. There were fewer articles mentioning medication other than asserting that medication must be combined with psychosocial interventions (14 versus 57 articles). Only 11/159 articles claimed that medication protects from school failure. These results were compared to those of our two previous studies. Thus, both French newspapers and the specialized press read by social workers mainly defended either the psychodynamic understanding of ADHD or a nuanced version of the biomedical model. In contrast, most French TV programmes described ADHD as an inherited neurological disease whose consequences on school failure can be counteracted by a very effective medication.

show abstract

Section: Resultsmentioning

confidence: 57%

Section: Introductionmentioning

confidence: 99%

How French media have portrayed ADHD to the lay public and to social workers

Ponnou

Gonon

2017

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

show abstract

“…One need only look at the epidemic scale increase in the diagnosis of attention deficit hyperactivity disorder (ADHD) and the concomitant increase in the use of prescription drugs [80][81][82]. While the symptoms ADHD may be better prevented by a cultural change, re-assessing the demands placed on children and providing an educational environment more in tune with children's innate learning abilities [83], the corporate interests of pharmaceutical companies appear to be winning out as drug sales soar [82]. Precision medicine will likely create further situations where the interests of patients, clinicians, insurance companies, government agencies, and the pharmaceutical industry do not fully coincide [19].…”

Section: Precision Medicine Revolution or Rebranding?mentioning

confidence: 99%

“…Disputes will also likely arise about whether precision treatments should be pharmaceutically or lifestyle based. One need only look at the epidemic scale increase in the diagnosis of attention deficit hyperactivity disorder (ADHD) and the concomitant increase in the use of prescription drugs [80][81][82]. While the symptoms ADHD may be better prevented by a cultural change, re-assessing the demands placed on children and providing an educational environment more in tune with children's innate learning abilities [83], the corporate interests of pharmaceutical companies appear to be winning out as drug sales soar [82].…”

Section: Precision Medicine Revolution or Rebranding?mentioning

confidence: 99%

Problems, challenges and promises: perspectives on precision medicine

Duffy¹

2015

Brief Bioinform

110

View full text Add to dashboard Cite

Conflicts of interest:The author discloses no potential conflicts of interest. Summary key points•Introduction of precision medicine/systems medicine concepts and approaches• Review of some of the challenges to the clinical implementation of precision medicine• Outline of methodologies being employed to overcome these challenges• Examination of the claims that precision medicine has overpromised Author biographyDavid J. Duffy is primarily an experimentalist, based at Systems Biology Ireland in University College Dublin. His research interests include cancer biology and evolutionary developmental biology and the application of omic technologies and systems medicine approaches to address questions in these fields. AbstractThe precision medicine (systems medicine) concept promises to achieve a shift to future

show abstract

“…In the USA it is estimated that 11% of children aged between 4 and 17 have been diagnosed with ADHD and between half and two-thirds of these are then prescribed stimulants (Sharpe, 2014). In the UK prescribing of stimulants rose from about 6000 prescriptions a year in 1994 to over 1 million by 2013; a staggering 17,000% rise in two decades (Timimi, 2015).…”

mentioning

confidence: 99%

Non-diagnostic based approaches to helping children who could be labelled ADHD and their families

Timimi

2017

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

Mental health services are not always good for you. There are some troubling facts to confront such as the increase in the use of diagnostic based approaches and psychotropic medications for children and young people being associated with poorer rather than better outcomes. In this article I will outline some of the evidence around outcome as a result of treatment for young people diagnosed with attention deficit hyperactivity disorder (ADHD) and for those who are prescribed long-term stimulants. I will then discuss clinical approaches that move beyond a focus on symptom management that diagnostic paradigms encourage. This includes clinical models that take account of the diversity of contextual and relational issues that young patients present with and the possibility afforded of engaging in more positive and hopeful therapeutic approaches such as the Relational Awareness Programme (RAP).

show abstract

Medication: The smart-pill oversell

Cited by 26 publications

References 9 publications

How French media have portrayed ADHD to the lay public and to social workers

How French media have portrayed ADHD to the lay public and to social workers

Problems, challenges and promises: perspectives on precision medicine

Non-diagnostic based approaches to helping children who could be labelled ADHD and their families

Contact Info

Product

Resources

About